GSK hires RAPP for global NiQuitin CQ and Alli accounts
By Matt Williams, Campaign ON 11 JUNE 2009
LONDON - GlaxoSmithKline, the healthcare giant, has handed Rapp the global direct marketing and digital accounts for its NiQuitin CQ and Alli brands after a pitch against LBi, Razorfish and EHS Brann.
NiQuitin CQ...moved to Rapp
The review was first called in April, and was handled by Agency Assessments.
In the UK, Rapp does not currently work with any GSK brands, but in the US it already handles the Alli range.
The agency will now be responsible for developing each brand's global strategies, working across direct marketing, digital, CRM and eCRM.
The first pieces of work, which will include the launch of a new website, are expected to roll out in the autumn.
NiQuitin's current below-the-line work is built around its Click2Quit scheme, which offers consumers advice to help them give up smoking.
The campaign gives users the ability to create their own personal plan to help them stop smoking, and informs them about the NiQuitin products that are on offer.
http://www.campaignlive.co.uk/news/search/912531/GSK-hires-Rapp-global-NiQuitin-CQ-Alli-accounts/
RAPP scoops Marketing's Direct Agency of the Year accolade
The transformed RAPP has innovated and developed its focus on digital and environmental work for client advertisers as part of its successful push to reposition itself.
MORE >
The Guardian: RAPP on mobile
It's been a while coming, but mobile applications are beginning to find widespread approval - and generate revenues as a result.
MORE >
Skype appoints "impressive" Rapp to expanded global positioning task
LONDON - Skype has awarded its $80m global ad account to an Omnicom trio of agencies, expanding the brief to include Rapp for CRM activity.
MORE >